Bowler Russell P, Kim Victor, Regan Elizabeth, Williams André A A, Santorico Stephanie A, Make Barry J, Lynch David A, Hokanson John E, Washko George R, Bercz Peter, Soler Xavier, Marchetti Nathaniel, Criner Gerard J, Ramsdell Joe, Han MeiLan K, Demeo Dawn, Anzueto Antonio, Comellas Alejandro, Crapo James D, Dransfield Mark, Wells J Michael, Hersh Craig P, MacIntyre Neil, Martinez Fernando, Nath Hrudaya P, Niewoehner Dennis, Sciurba Frank, Sharafkhaneh Amir, Silverman Edwin K, van Beek Edwin J R, Wilson Carla, Wendt Christine, Wise Robert A
Department of Medicine, National Jewish Health, Denver, CO.
Department of Medicine, Section of Pulmonary and Critical Care Medicine, Temple University, Philadelphia PA.
Chest. 2014 Oct;146(4):941-950. doi: 10.1378/chest.13-2946.
The risk factors for acute episodes of respiratory disease in current and former smokers who do not have COPD are unknown.
Eight thousand two hundred forty-six non-Hispanic white and black current and former smokers in the Genetic Epidemiology of COPD (COPDGene) cohort had longitudinal follow-up (LFU) every 6 months to determine acute respiratory episodes requiring antibiotics or systemic corticosteroids, an ED visit, or hospitalization. Negative binomial regression was used to determine the factors associated with acute respiratory episodes. A Cox proportional hazards model was used to determine adjusted hazard ratios (HRs) for time to first episode and an acute episode of respiratory disease risk score.
At enrollment, 4,442 subjects did not have COPD, 658 had mild COPD, and 3,146 had moderate or worse COPD. Nine thousand three hundred three acute episodes of respiratory disease and 2,707 hospitalizations were reported in LFU (3,044 acute episodes of respiratory disease and 827 hospitalizations in those without COPD). Major predictors included acute episodes of respiratory disease in year prior to enrollment (HR, 1.20; 95% CI, 1.15-1.24 per exacerbation), airflow obstruction (HR, 0.94; 95% CI, 0.91-0.96 per 10% change in % predicted FEV1), and poor health-related quality of life (HR, 1.07; 95% CI, 1.06-1.08 for each 4-unit increase in St. George's Respiratory Questionnaire score). Risks were similar for those with and without COPD.
Although acute episode of respiratory disease rates are higher in subjects with COPD, risk factors are similar, and at a population level, there are more episodes in smokers without COPD.
目前尚不清楚没有慢性阻塞性肺疾病(COPD)的现吸烟者和 former smokers 发生呼吸系统疾病急性发作的危险因素。
慢性阻塞性肺疾病基因流行病学(COPDGene)队列中的8246名非西班牙裔白人和黑人现吸烟者和 former smokers 每6个月进行一次纵向随访(LFU),以确定需要使用抗生素或全身性皮质类固醇、急诊就诊或住院治疗的急性呼吸道发作情况。采用负二项回归来确定与急性呼吸道发作相关的因素。使用Cox比例风险模型来确定首次发作时间的调整风险比(HRs)和呼吸系统疾病急性发作风险评分。
入组时,4442名受试者没有COPD,658名患有轻度COPD,3146名患有中度或更严重的COPD。在纵向随访中报告了9303次呼吸系统疾病急性发作和2707次住院(没有COPD的患者中有3044次呼吸系统疾病急性发作和827次住院)。主要预测因素包括入组前一年的呼吸系统疾病急性发作(HR,1.20;95%CI,每次发作1.15 - 1.24)、气流阻塞(HR,0.94;95%CI,预测FEV1百分比每变化10%为0.91 - 0.96)以及健康相关生活质量差(HR,圣乔治呼吸问卷评分每增加4分,1.07;95%CI,1.06 - 1.08)。有COPD和没有COPD的患者风险相似。
虽然COPD患者呼吸系统疾病急性发作率较高,但危险因素相似,且在人群水平上,没有COPD的吸烟者发作次数更多。